Source:http://linkedlifedata.com/resource/pubmed/id/14970517
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-2-18
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1064-3745
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
248
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-18
|
pubmed:meshHeading |
pubmed-meshheading:14970517-Animals,
pubmed-meshheading:14970517-Base Sequence,
pubmed-meshheading:14970517-Cell Line, Tumor,
pubmed-meshheading:14970517-DNA, Complementary,
pubmed-meshheading:14970517-DNA Primers,
pubmed-meshheading:14970517-Immunotoxins,
pubmed-meshheading:14970517-Neoplasms,
pubmed-meshheading:14970517-Recombinant Proteins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Recombinant immunotoxins in the treatment of cancer.
|
pubmed:affiliation |
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
|
pubmed:publicationType |
Journal Article
|